NBT Bank N A NY trimmed its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 11.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 25,305 shares of the financial services provider's stock after selling 3,343 shares during the period. NBT Bank N A NY's holdings in Marsh & McLennan Companies were worth $6,175,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in MMC. Norges Bank acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $1,236,186,000. Stifel Financial Corp increased its position in Marsh & McLennan Companies by 551.0% during the fourth quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider's stock worth $472,599,000 after buying an additional 1,883,146 shares in the last quarter. Amundi raised its holdings in shares of Marsh & McLennan Companies by 81.1% in the fourth quarter. Amundi now owns 4,072,976 shares of the financial services provider's stock worth $860,824,000 after acquiring an additional 1,823,807 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Marsh & McLennan Companies by 32,120.9% in the first quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider's stock valued at $369,869,000 after acquiring an additional 1,510,966 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Marsh & McLennan Companies during the 4th quarter worth about $207,278,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Stock Down 0.4%
Shares of NYSE:MMC opened at $216.49 on Tuesday. The stock has a 50-day simple moving average of $226.35 and a 200-day simple moving average of $225.17. The stock has a market capitalization of $106.67 billion, a P/E ratio of 26.43, a PEG ratio of 2.70 and a beta of 0.83. Marsh & McLennan Companies, Inc. has a 1 year low of $207.21 and a 1 year high of $248.00. The company has a debt-to-equity ratio of 1.44, a quick ratio of 1.13 and a current ratio of 1.13.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. The company had revenue of $6.70 billion during the quarter, compared to analyst estimates of $7.08 billion. During the same quarter in the prior year, the business earned $2.89 earnings per share. Equities analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current year.
Insiders Place Their Bets
In other news, CEO Dean Michael Klisura sold 9,569 shares of the business's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $245.00, for a total value of $2,344,405.00. Following the completion of the sale, the chief executive officer now directly owns 20,935 shares in the company, valued at approximately $5,129,075. The trade was a 31.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Paul Beswick sold 2,237 shares of the firm's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $246.00, for a total value of $550,302.00. Following the transaction, the senior vice president now owns 13,522 shares in the company, valued at $3,326,412. This trade represents a 14.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on MMC shares. Barclays raised their price target on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Redburn Atlantic assumed coverage on shares of Marsh & McLennan Companies in a research note on Tuesday, March 25th. They set a "buy" rating and a $281.00 price objective on the stock. Keefe, Bruyette & Woods lowered their target price on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating for the company in a research note on Monday, April 21st. Wells Fargo & Company increased their price target on Marsh & McLennan Companies from $223.00 to $232.00 and gave the stock an "equal weight" rating in a research note on Thursday, April 10th. Finally, UBS Group lifted their price objective on Marsh & McLennan Companies from $259.00 to $261.00 and gave the company a "buy" rating in a research report on Wednesday, April 9th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $241.93.
Read Our Latest Stock Report on MMC
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.